Healthcare - Sector
KROS is currently covered by 2 analysts with an average price target of $19. This is a potential upside of $7.92 (71.48%) from yesterday's end of day stock price of $11.08.
Keros Therapeutics's activity chart (see below) currently has 97 price targets and 82 ratings on display. The stock rating distribution of KROS is 50% BUY and 50% HOLD.
Analysts' price targets on this stock were met 35.17% of the time, taking 72.52 days on average.
Highest price target for KROS is $20, Lowest price target is $18, average price target is $19.
Most recent stock forecast was given by BENJAMIN BURNETT from WELLS FARGO on 04-Aug-2026. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 2 are a HOLD (50%), 2 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Mar-2026
$18
$6.92 (62.45%)
$20
3 months 17 days ago
(04-Aug-2026)
0/3 (0%)
$7.75 (75.61%)
Hold Since 28-Nov-2025
$19
$8.01 (72.88%)
$18
11 months 24 days ago
(28-Nov-2025)
2/2 (100%)
$1.52 (8.70%)
91
Buy Since 31-Jul-2023
$27
$23
1 years 9 days ago
(12-Nov-2025)
0/8 (0%)
$9.53 (54.55%)
Hold Since 01-Apr-2025
$16
$15
1 years 15 days ago
(06-Nov-2025)
4/4 (100%)
$-0.17 (-1.05%)
80
Buy Since 04-May-2020
$20
$25
1 years 3 months 11 days ago
(10-Aug-2025)
2/15 (13.33%)
$6.27 (45.67%)
115
What is KROS (Keros Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KROS (Keros Therapeutics)?
Which analyst has the most public recommendations on KROS (Keros Therapeutics)?
Which analyst is the currently most bullish on KROS (Keros Therapeutics)?
Which analyst is the currently most reserved on KROS (Keros Therapeutics)?